NEW DELHI: Defending his covid-19 vaccine Covaxin from criticism by various experts, Bharat Biotech International Ltd chairman and managing director Krishna Ella on Monday said that the company would in a week come out with data proving that his vaccine can work against the new mutant strain of novel coronavirus.“It’s only a hypothesis right now...
Just give me one week’s time to come out with the data. I am confident it will work," Ella said when asked about the studies the company was conducting on the mutant strains of novel coronavirus.Protection against the more virulent mutated strain of the virus from UK was the major reason for the company getting an authorisation from the Drugs Controller General of India V.G.